Stock listing

Nektar Therapeutics

Selected listing: ITH0 · GETTEX · EUR · DE

Nektar Therapeutics (gettex:ITH0), Health Technology. Latest release Oct 1, 2026: /UPDATE -- Nektar Therapeutics/.

ITH0:GETTEXEURDEUpdated September 25, 2026

Ticker: gettex:ITH0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: gettex
Currency: EUR

About Nektar Therapeutics

The company focuses on developing innovative therapies to address unmet medical needs. Nektar is dedicated to advancing its pipeline of drug candidates and improving patient outcomes.

Latest news from Nektar Therapeutics

/UPDATE -- Nektar Therapeutics/

September 30, 2026

New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026

October 1, 2026

New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis

September 30, 2026

Nektar Announces Three Oral Presentations for Rezpegaldesleukin at the European Academy of Dermatology & Venereology (EADV) Congress 2026

September 28, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)

August 31, 2026

All Nektar Therapeutics news →

Events

Replays

Nektar Therapeutics (NKTR) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 05:00 PM ET
Watch
Nektar Therapeutics (NKTR) Q1 2026 Earnings Call
Thu, May 07, 2026 · 05:00 PM ET
Watch
Nektar Therapeutics (NKTR) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 05:00 PM ET
Watch

Research Nektar Therapeutics

Nektar Therapeutics company profile

View the public company page for Nektar Therapeutics on 6ix.

Nektar Therapeutics news

Read company news and market updates connected to Nektar Therapeutics.

Nektar Therapeutics investor events

Find investor webinars, events, and replay context for Nektar Therapeutics.